SCHEMBL2738822

SCHEMBL2738822

O=C(O)c1cn(C2CC2)c2cc(N3CCN(P(=O)(O)O)CC3)c(F)cc2c1=O

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.73
▸ ALDH1A1 P00352 4/20 0.73
▸ LMNA P02545 3/20 0.73
▸ HPGD P15428 2/20 0.73
▸ HSD17B10 Q99714 2/20 0.73
▸ CYP1A2 P05177 1/20 0.73
▸ TOP2A P11388 1/20 0.73
▸ CYP2C9 P11712 1/20 0.73
▸ TOP2B Q02880 1/20 0.73
▸ MAPT P10636 1/20 0.72
▸ PIK3CG P48736 7/20 0.62
▸ PIK3CD O00329 5/20 0.62
▸ PIK3R1 P27986 5/20 0.62
▸ PIK3CA P42336 5/20 0.62
▸ HTT P42858 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ HRH3 Q9Y5N1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13464168 0.92 KDM4E (0.74) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13226802 0.89 KDM4E (0.75) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL2738823 0.89 KDM4E (0.70) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL2738824 0.88 KDM4E (0.71) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL10736589 0.87 KDM4E (0.79) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL10374013 0.87 KDM4E (0.79) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL14159326 0.87 KDM4E (0.82) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL9145542 0.87 KDM4E (0.82) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL2738825 0.87 KDM4E (0.64) KDM4EALDH1A1LMNAHPGDHSD17B10
Ciprofloxacin SCHEMBL9788113 0.87 KDM4E (0.92) KDM4EALDH1A1LMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088918-B2 Noncardiotoxic pharmaceutical compounds WILLIAMSBURG HOLDINGS LLC (US) 2012-01-03 — — US disclosed
US-8088918-B2 Noncardiotoxic pharmaceutical compounds WILLIAMSBURG HOLDINGS LLC (US) 2012-01-03 — — US disclosed
US-5212291-A Anthracycline derivatives as solubilized pro-drugs AMERICAN CYANAMID COMPANY (US) 1993-05-18 — — US disclosed
US-5116827-A Antitumor agents AMERICAN CYANAMID COMPANY (US) 1992-05-26 — — US disclosed
US-5077283-A Enhanced water and lipid solubility; antitumor, anticarcinogen ic agents AMERICAN CYANAMID COMPANY (US) 1991-12-31 — — US disclosed
US-5077282-A Improved water or lipid solubility and reduced toxicity AMERICAN CYANAMID COMPANY (US) 1991-12-31 — — US disclosed
US-5070082-A PHOSPHORYLATED DERIVATIVE OF PENTAMIDINE AMERICAN CYANAMID COMPANY (US) 1991-12-03 — — US disclosed
EP-0338372-A2 Solubilized pro-drugs AMERICAN CYANAMID COMPANY (US) 1989-10-25 — — EP disclosed
Send feedback